Filing Details
- Accession Number:
- 0000950170-23-018413
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-05 18:27:56
- Reporting Period:
- 2023-05-05
- Accepted Time:
- 2023-05-05 18:27:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840229 | Mink Therapeutics Inc. | INKT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 935679 | H Garo Armen | 149 Fifth Avenue, Suite 500 New York NY 10010 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-05 | 100,000 | $0.95 | 1,866,400 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On May 5, 2023, Garo Armen sold 100,000 shares of Mink Therapeutics, Inc. common stock to Agenus Inc. at the acquisition price he paid on May 2, 2023. The acquisition price represents a 40% discount to the market price as of today's market close. Garo Armen did not recognize a profit upon the sale of the shares.
Billionaire Hedge Funds
